THE EFFECT OF ACETAMINOPHEN ON THE DISPOSITION OF FENOLDOPAM - COMPETITION FOR SULFATION

被引：20

作者：

ZIEMNIAK, JA ^{[1
]}

ALLISON, N ^{[1
]}

BOPPANA, VK ^{[1
]}

DUBB, J ^{[1
]}

STOTE, R ^{[1
]}

机构：

[1] SK&F LABS,DEPT DRUG METAB & CLIN RES & DEV,SWEDELAND,PA 19479

来源：

CLINICAL PHARMACOLOGY & THERAPEUTICS | 1987年 / 41卷 / 03期

关键词：

D O I：

10.1038/clpt.1987.28

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：275 / 281

页数：7

共 16 条

[1] RENAL VASODILATORS AND HYPERTENSION [J].

ACKERMAN, DM ;

WEINSTOCK, J ;

WIEBELHAUS, VD ;

BERKOWITZ, B .

DRUG DEVELOPMENT RESEARCH, 1982, 2 (03) :283-297

[2]

BOPPANA VK, 1984, J CHROMATOGR, V317, P463, DOI 10.1016/S0021-9673(01)91686-3

[3] USE OF A POSTCOLUMN IMMOBILIZED BETA-GLUCURONIDASE ENZYME REACTOR FOR THE DETERMINATION OF DIASTEREOMERIC GLUCURONIDES OF FENOLDOPAM IN PLASMA AND URINE BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY WITH ELECTROCHEMICAL DETECTION [J].

BOPPANA, VK ;

FONG, KLL ;

ZIEMNIAK, JA ;

LYNN, RK .

JOURNAL OF CHROMATOGRAPHY, 1986, 353 :231-247

[4]

CALDWELL T, 1978, CONJUGATION REACTION, P477

[5] THE EFFECT OF ORAL FENOLDOPAM (SKF 82526-J), A PERIPHERAL DOPAMINE RECEPTOR AGONIST, ON BLOOD-PRESSURE AND RENAL-FUNCTION IN NORMAL MAN [J].

HARVEY, JN ;

WORTH, DP ;

BROWN, J ;

LEE, MR .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1985, 19 (01) :21-27

[6]

KRIGSHELD KR, 1982, SULFATE METABOLISM S, P59

[7]

KRIGSHELD KR, 1981, BIOCHEM PHARMACOL, V30, P1973

[8] DRUG BIOTRANSFORMATION INTERACTIONS IN MAN .3. ACETAMINOPHEN AND SALICYLAMIDE [J].

LEVY, G ;

YAMADA, H .

JOURNAL OF PHARMACEUTICAL SCIENCES, 1971, 60 (02) :215-&

[9]

LEVY G, 1967, J PHARMACOL EXP THER, V156, P285

[10] PHARMACOKINETIC CONSEQUENCES AND TOXICOLOGIC IMPLICATIONS OF ENDOGENOUS COSUBSTRATE DEPLETION [J].

LEVY, G ;

GALINSKY, RE ;

LIN, JH .

DRUG METABOLISM REVIEWS, 1982, 13 (06) :1009-1020

← 1 2 →